Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
暂无分享，去创建一个
J. Bading | B. Badie | M. D'Apuzzo | S. Forman | Christine E. Brown | M. Jensen | L. Weng | J. Ostberg | R. Starr | C. Wright | M. Barish | Wen-Chung Chang | Araceli Naranjo | J. Wagner | Yubo Zhai | J. Ressler | J. Portnow | A. Naranjo | M. D’Apuzzo | W. Chang